| LDLRX | VSCSX | LDLRX / VSCSX | |
| Total Expense Ratio | 0.89 | 0.06 | 1,483% |
| Annual Report Gross Expense Ratio | 0.89 | 0.06 | 1,483% |
| Fund Existence | 17 years | 16 years | - |
| Gain YTD | 0.575 | 0.706 | 82% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 43.7B | 49.2B | 89% |
| Annual Yield % from dividends | 4.64 | 4.03 | 115% |
| Returns for 1 year | 4.18 | 4.63 | 90% |
| Returns for 3 years | 15.44 | 17.58 | 88% |
| Returns for 5 years | 10.86 | 11.89 | 91% |
| Returns for 10 years | 26.36 | 30.36 | 87% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| MSTZ | 9.11 | 1.12 | +14.02% |
| T-REX 2X Inverse MSTR Daily Target ETF | |||
| VTES | 101.11 | 0.01 | +0.01% |
| Vanguard Short-Term Tax-Exmpt Bd ETF | |||
| QCJA | 23.36 | -0.02 | -0.09% |
| FT Vest Nasdaq-100 Cnsrv Buffr ETF - Jan | |||
| UJAN | 45.30 | -0.06 | -0.12% |
| Innovator US Equity Ultra Buff ETF™ Jan | |||
| ITDG | 42.18 | -0.34 | -0.79% |
| iShares LifePath Target Date 2055 ETF | |||